- Home
- ATAI vs OSUR Comparison
ATAI vs OSUR Comparison
Compare ATAI & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATAI | OSUR |
|---|---|---|
| Founded | 2018 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 215.9M |
| IPO Year | 2025 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ATAI | OSUR |
|---|---|---|
| Price | $3.99 | $3.08 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 2 |
| Target Price | ★ $15.88 | $3.00 |
| AVG Volume (30 Days) | ★ 7.0M | 509.3K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,089,000.00 | ★ $167,064,000.00 |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1227.60 | N/A |
| 52 Week Low | $1.66 | $2.08 |
| 52 Week High | $6.73 | $3.76 |
Technical Indicators
Market Signals| Indicator | ATAI | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 46.42 | 53.63 |
| Support Level | $3.89 | $2.87 |
| Resistance Level | $4.13 | $3.24 |
| Average True Range (ATR) | 0.22 | 0.14 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 14.17 | 60.38 |
Price Performance
Historical ComparisonAbout ATAI ATAI Life Sciences N.V.
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.